Siegel recommends patients view maintenance dosing the same way they would consider ongoing medication for any other chronic condition
Patients on SSRIs actually lost slightly more weight on average: 10.7%-19% of their bodyweight, as opposed to non-SSRI patients losing 9.5%-15.9% on average
A specific role for IGF-1 receptor (IGF-1R) signaling in the mediation of mammalian longevity was first established in IGF-1R haploinsufficient mice, which lived 33% longer than controls, but unlike other models of reduced somatotropic signaling, this effect was female specific 6
While berberine is a potent metabolic tool, your safety is the priority
Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher
Traveling with GLP-1 medications like tirzepatide or semaglutide requires careful planning to ensure the medication remains effective and that your journey through security is seamless